These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15881181)

  • 1. [Probiotics and prebiotics for the treatment of inflammatory bowel disease].
    Mitsuyama K
    Nihon Rinsho; 2005 May; 63(5):850-8. PubMed ID: 15881181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microflora as a therapeutic target in inflammatory bowel disease.
    Mitsuyama K; Toyonaga A; Sata M
    J Gastroenterol; 2002 Nov; 37 Suppl 14():73-7. PubMed ID: 12572870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics and prebiotics in chronic inflammatory bowel diseases.
    Ewaschuk JB; Dieleman LA
    World J Gastroenterol; 2006 Oct; 12(37):5941-50. PubMed ID: 17009391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.
    Damaskos D; Kolios G
    Br J Clin Pharmacol; 2008 Apr; 65(4):453-67. PubMed ID: 18279467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
    Verbeke KA; Boesmans L; Boets E
    Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
    Heilpern D; Szilagyi A
    Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.
    Rioux KP; Madsen KL; Fedorak RN
    Gastroenterol Clin North Am; 2005 Sep; 34(3):465-82, ix. PubMed ID: 16084308
    [No Abstract]   [Full Text] [Related]  

  • 10. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
    Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
    Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of intestinal flora in the treatment of inflammatory bowel disease.
    Kanauchi O; Mitsuyama K; Araki Y; Andoh A
    Curr Pharm Des; 2003; 9(4):333-46. PubMed ID: 12570821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?
    Cary VA; Boullata J
    J Clin Nurs; 2010 Apr; 19(7-8):904-16. PubMed ID: 20492035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of probiotics in inflammatory bowel disease.
    Cain AM; Karpa KD
    Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
    Roy S; Dhaneshwar S
    World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prebiotics in chronic intestinal inflammation.
    Looijer-van Langen MA; Dieleman LA
    Inflamm Bowel Dis; 2009 Mar; 15(3):454-62. PubMed ID: 18831524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health, probiotics, and inflammation.
    Mengheri E
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S177-8. PubMed ID: 18685508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.
    Sartor RB
    Gastroenterology; 2004 May; 126(6):1620-33. PubMed ID: 15168372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
    Meijer BJ; Dieleman LA
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic impact of manipulating microbiota in inflammatory bowel disease.
    Kanauchi O; Mitsuyama K; Andoh A
    Curr Pharm Des; 2009; 15(18):2074-86. PubMed ID: 19519445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.